| Analgesic Molecules......6
|
| Table 1: Analgesic Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Aspirin, Ibuprofen, Paracetamol and Others......6
|
| Antihypertensive Drugs......7
|
| Table 2: Antihypertensive Drugs Market by Product in China (2105) - Percentage Share Breakdown by Value for Angiotensin II Receptor Blockers (ARBs), Beta Blocker, Calcium Channel Blocker and Others......7
|
| Table 3: Hypertension Treatment Market by Segment in China (2015) - Percentage Share Breakdown by Value for Products to Regulate Blood Lipid Levels, and Products to Regulate Blood Sugar......8
|
| Pulmonary Arterial Hypertension (PAH)......9
|
| Table 4: Pulmonary Arterial Hypertension (PAH) Treatment by Drug Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Adcirca, Letairis/Volibris, Remodulin, Revatio, Tracleer, Tyvaso and Ventavis......9
|
| Table 5: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy Worldwide (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......10
|
| Table 6: Pulmonary Arterial Hypertension (PAH) Treatment with Macitentan Drug by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Japan, US and Rest of World......11
|
| Table 7: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......12
|
| Table 8: Pulmonary Arterial Hypertension (PAH) Treatment by Type Worldwide (2015) - Percentage Breakdown by Value for Inhaled Prostacyclins, Orals (ERAs, PDE5s, Prostacyclins), and Parenteral Prostacyclins......13
|
| Table 9: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in Europe (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......14
|
| Table 10: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in Europe (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......15
|
| Table 11: Pulmonary Arterial Hypertension Treatment Market by Product Segment in Japan (2015) - Percentage Share Breakdown by Value for Adcirca, Dorner, Flolan, Procylin, Revatio, and Tracleer......16
|
| Table 12: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in the US (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......17
|
| Table 13: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in the US (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......18
|
| Pulmonary Hypertension Drugs......19
|
| Table 14: Specialty Pulmonary Hypertension Drugs Benefit Market by Category in the US (2015) - Percentage Share Breakdown by Value for Medical Benefit and Pharmacy Benefit......19
|
| End-Stage Renal Disease (ESRD)......20
|
| Table 15: End-Stage Renal Disease (ESRD) Market by Cause in China (2015) - Percentage Share Breakdown by Value for Diabetic Nephropathy, Glomerular Disease, Hypertension Caused Renal Disease and Others......20
|
| Table 16: End-Stage Renal Disease (ESRD) Cases by Diagnosis in the US (2015) - Percentage Share Breakdown by Value for Cystic Kidney, Diabetes, Glomerulonephritis, Hypertension, and Others......21
|
| Speciality Pharmaceuticals......22
|
| Table 17: Speciality Pharmaceuticals Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......22
|
| Table 18: Speciality Drug Sales by Therapeutic Category in the US (2015) - Percentage Market Share Breakdown by Value for Anticoagulants, Cancer, Growth Deficiency, Hepatitis C, HIV, Inflammatory Conditions, Multiple Sclerosis, Pulmonary Hypertension, Respiratory Conditions, Transplant and Others......23
|
| Table 19: Specialty Pharmaceuticals Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Hepatitis, HIV & AIDS (including oral solids), Intravenous Immunoglobulin (Hemophilia), Multiple Sclerosis, Oncology (including oral solids), Renal, Rheumatoid Arthritis (Crohn's), and Others......24
|
| Anaesthetics & Analgesics......25
|
| Table 20: Market Shares of Leading Anaesthetics & Analgesics Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......25
|
| Table 21: Market Shares of Leading Analgesics Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......26
|
| Table 22: Market Shares of Leading Analgesics Manufacturers in Africa Middle East (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......27
|
| Table 23: Market Shares of Leading Analgesics Manufacturers in Asia-Pacific (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......28
|
| Table 24: Market Shares of Leading Analgesics Manufacturers in Europe (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......29
|
| Table 25: Market Shares of Leading Analgesic Product Manufacturers in India (2015) - Percentage Share Breakdown by Value for Emami Ltd., Glaxo SmithKline Consumer Healthcare Ltd., Reckitt Benckiser Group Plc, and Others......30
|
| Table 26: Market Shares of Leading Analgesic Products Brands in India (2015) - Percentage Share Breakdown by Value for Zandu Balm & Mentha Balm, and Others......31
|
| Table 27: Market Shares of Leading Analgesics Brands in Indonesia (2015) - Percentage Share Breakdown by Value for Bodrex (regular), Oskadon, Paramex, Puyer 16 and Others......32
|
| Table 28: Market Shares of Leading Analgesics Brands in Indonesia (2015) - Percentage Share Breakdown by Volume for Bodrex (regular), Oskadon, Paramex, Puyer 16 and Others......33
|
| Table 29: Market Shares of Leading Analgesics Manufacturers in Latin America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......34
|
| Table 30: Market Shares of Leading Analgesic Brands in Nigeria (2015) - Percentage Breakdown by Value for Alabukun, Emzor, Pandol, and Others......35
|
| Table 31: Market Shares of Leading Analgesics Manufacturers in North America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......36
|
| Table 32: Market Shares of Leading Analgesic (Internal Tablet) Manufacturers by Value Sales at Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Bayer Consumer Health Division, McNeil Consumer Products, Pfizer, Inc., Private Label, and Others......37
|
